<SEC-DOCUMENT>0001213900-25-120055.txt : 20251210
<SEC-HEADER>0001213900-25-120055.hdr.sgml : 20251210
<ACCEPTANCE-DATETIME>20251210154706
ACCESSION NUMBER:		0001213900-25-120055
CONFORMED SUBMISSION TYPE:	SCHEDULE 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20251210
DATE AS OF CHANGE:		20251210

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Enveric Biosciences, Inc.
		CENTRAL INDEX KEY:			0000890821
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				954484725
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-53543
		FILM NUMBER:		251561853

	BUSINESS ADDRESS:	
		STREET 1:		245 FIRST STREET RIVERVIEW II 18TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		239-302-1707

	MAIL ADDRESS:	
		STREET 1:		245 FIRST STREET RIVERVIEW II 18TH FLOOR
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	AMERI Holdings, Inc.
		DATE OF NAME CHANGE:	20150527

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SPATIALIZER AUDIO LABORATORIES INC
		DATE OF NAME CHANGE:	19950323

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			NORTHSTRIVE FUND II LP
		CENTRAL INDEX KEY:			0002099270
		ORGANIZATION NAME:           	
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SCHEDULE 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		120 NEWPORT CENTER DR
		STREET 2:		STE 250
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			926660
		BUSINESS PHONE:		9498757003

	MAIL ADDRESS:	
		STREET 1:		120 NEWPORT CENTER DR
		STREET 2:		STE 250
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			926660
</SEC-HEADER>
<DOCUMENT>
<TYPE>SCHEDULE 13G/A
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/schedule13g" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>SCHEDULE 13G/A</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <!-- Field: Pseudo-Tag; ID: Name; Data: NORTHSTRIVE FUND II LP -->
          <cik>0002099270</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <coverPageHeader>
      <amendmentNo>1</amendmentNo>
      <securitiesClassTitle>Common Stock, $0.01 par value per share</securitiesClassTitle>
      <eventDateRequiresFilingThisStatement>12/09/2025</eventDateRequiresFilingThisStatement>
      <issuerInfo>
        <issuerCik>0000890821</issuerCik>
        <issuerName>ENVERIC BIOSCIENCES, INC.</issuerName>
        <issuerCusip>29405E505</issuerCusip>
        <issuerPrincipalExecutiveOfficeAddress>
          <com:street1>245 First Street, Riverview II, 18th Flo</com:street1>
          <com:city>Cambridge</com:city>
          <com:stateOrCountry>MA</com:stateOrCountry>
          <com:zipCode>02142</com:zipCode>
        </issuerPrincipalExecutiveOfficeAddress>
      </issuerInfo>
      <designateRulesPursuantThisScheduleFiled>
        <designateRulePursuantThisScheduleFiled>Rule 13d-1(d)</designateRulePursuantThisScheduleFiled>
      </designateRulesPursuantThisScheduleFiled>
    </coverPageHeader>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Northstrive Fund II LP</reportingPersonName>
      <citizenshipOrOrganization>DE</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>0.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0</classPercent>
      <typeOfReportingPerson>PN</typeOfReportingPerson>
      <comments>Mr. Lichti is, as of the date of this Amendment No. 1 to Schedule 13G ("Amendment No. 1"), the Manager of Northstrive Fund II LP. As of December 9, 2025, (please refer to Item 4 of this Amendment No. 1, below, for additional detail in relation to this date), the Reporting Person(s) are no longer beneficial owners or no longer deemed to be beneficial owners of any shares of Common Stock of Enveric Biosciences, Inc., a Delaware corporation (the "Issuer").</comments>
    </coverPageHeaderReportingPersonDetails>
    <coverPageHeaderReportingPersonDetails>


      <reportingPersonName>Braeden Lichti</reportingPersonName>
      <citizenshipOrOrganization>Z4</citizenshipOrOrganization>
      <reportingPersonBeneficiallyOwnedNumberOfShares>
        <soleVotingPower>0.00</soleVotingPower>
        <sharedVotingPower>0.00</sharedVotingPower>
        <soleDispositivePower>0.00</soleDispositivePower>
        <sharedDispositivePower>0.00</sharedDispositivePower>
      </reportingPersonBeneficiallyOwnedNumberOfShares>
      <reportingPersonBeneficiallyOwnedAggregateNumberOfShares>0.00</reportingPersonBeneficiallyOwnedAggregateNumberOfShares>
      <aggregateAmountExcludesCertainSharesFlag>N</aggregateAmountExcludesCertainSharesFlag>
      <classPercent>0</classPercent>
      <typeOfReportingPerson>IN</typeOfReportingPerson>
      <comments>Mr. Lichti is, as of the date of this Amendment No. 1, the Manager of Northstrive Fund II LP. As of December 9, 2025, (please refer to Item 4 of this Amendment No. 1, below, for additional detail in relation to this date), the Reporting Person(s) are no longer beneficial owners or no longer deemed to be beneficial owners of any shares of Common Stock of the Issuer.</comments>
    </coverPageHeaderReportingPersonDetails>
    <items>
      <item1>
        <issuerName>ENVERIC BIOSCIENCES, INC.</issuerName>
        <issuerPrincipalExecutiveOfficeAddress>245 First Street, Riverview II, 18th Floor, Cambridge, MA 02142</issuerPrincipalExecutiveOfficeAddress>
      </item1>
      <item2>
        <filingPersonName>This statement is filed by:

(i) Northstrive Fund II LP, a Delaware limited partnership; and

(ii) Braeden Lichti ("Mr. Lichti").

The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."</filingPersonName>
        <principalBusinessOfficeOrResidenceAddress>120 Newport Center Drive, Suite 250
Newport Beach, CA 92660</principalBusinessOfficeOrResidenceAddress>
        <citizenship>Northstrive Fund II LP is a Delaware corporation. Mr. Lichti is a citizen of Canada.</citizenship>
      </item2>
      <item3>
        <notApplicableFlag>Y</notApplicableFlag>
      </item3>
      <item4>
        <amountBeneficiallyOwned>Pursuant to Rule 13d-2 promulgated under the Securities Exchange Act of 1934, as amended, this Amendment No. 1 to Schedule 13G/A (this "Amendment No. 1") amends and supplements the Schedule 13G originally filed with the U.S. Securities and Exchange Commission on December 5, 2025 (the "Original Schedule 13G").

This Amendment No. 1 relates to the Common Stock of the Issuer, owned by the Reporting Persons and is the final amendment to the Original Schedule 13G and an exit filing for the Reporting Persons.</amountBeneficiallyOwned>
        <classPercent>Northstrive Fund II LP: 0%
Braeden Lichti: 0%</classPercent>
        <numberOfSharesPersonHas>
          <solePowerOrDirectToVote>Northstrive Fund II LP: 0

Braeden Lichti: 0</solePowerOrDirectToVote>
          <sharedPowerOrDirectToVote>Northstrive Fund II LP: 0

Braeden Lichti: 0</sharedPowerOrDirectToVote>
          <solePowerOrDirectToDispose>Northstrive Fund II LP: 0

Braeden Lichti: 0</solePowerOrDirectToDispose>
          <sharedPowerOrDirectToDispose>Northstrive Fund II LP: 0

Braeden Lichti: 0</sharedPowerOrDirectToDispose>
        </numberOfSharesPersonHas>
      </item4>
      <item5>
        <notApplicableFlag>Y</notApplicableFlag>
      </item5>
      <item6>
        <notApplicableFlag>Y</notApplicableFlag>
      </item6>
      <item7>
        <notApplicableFlag>Y</notApplicableFlag>
      </item7>
      <item8>
        <notApplicableFlag>Y</notApplicableFlag>
      </item8>
      <item9>
        <notApplicableFlag>Y</notApplicableFlag>
      </item9>
      <item10>
        <notApplicableFlag>Y</notApplicableFlag>
      </item10>
    </items>
    <signatureInformation>
      <reportingPersonName>Northstrive Fund II LP</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Braeden Lichti</signature>
        <title>Braeden Lichti, Manager</title>
        <date>12/10/2025</date>
      </signatureDetails>
    </signatureInformation>
    <signatureInformation>
      <reportingPersonName>Braeden Lichti</reportingPersonName>
      <signatureDetails>
        <signature>/s/ Braeden Lichti</signature>
        <title>Braeden Lichti</title>
        <date>12/10/2025</date>
      </signatureDetails>
    </signatureInformation>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
